Healthequity Trade and Non Trade Receivables vs Investments Current Analysis

HQY
 Stock
  

USD 60.09  2.75  4.80%   

Healthequity financial indicator trend analysis is much more than just examining Healthequity latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Healthequity is a good investment. Please check the relationship between Healthequity Trade and Non Trade Receivables and its Investments Current accounts. Please check Risk vs Return Analysis.

Trade and Non Trade Receivables vs Investments Current

Trade and Non Trade Receivables vs Investments Current Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Healthequity Trade and Non Trade Receivables account and Investments Current. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Healthequity's Trade and Non Trade Receivables and Investments Current is 0.8. Overlapping area represents the amount of variation of Trade and Non Trade Receivables that can explain the historical movement of Investments Current in the same time period over historical financial statements of Healthequity, assuming nothing else is changed. The correlation between historical values of Healthequity's Trade and Non Trade Receivables and Investments Current is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Trade and Non Trade Receivables of Healthequity are associated (or correlated) with its Investments Current. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Investments Current has no effect on the direction of Trade and Non Trade Receivables i.e., Healthequity's Trade and Non Trade Receivables and Investments Current go up and down completely randomly.

Correlation Coefficient

0.8
Relationship DirectionPositive 
Relationship StrengthStrong

Trade and Non Trade Receivables

A component of Total Assets representing trade and non-trade receivables.

Investments Current

The current portion of Investments; reported if the company operates a classified balance sheet that segments current and non-current assets.
Most indicators from Healthequity fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Healthequity current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please check Risk vs Return Analysis.Healthequity Selling General and Administrative Expense is fairly stable at the moment as compared to the past year. Healthequity reported Selling General and Administrative Expense of 142.98 Million in 2021. Issuance Purchase of Equity Shares is likely to rise to about 503.2 M in 2022, whereas Net Cash Flow Business Acquisitions and Disposals is likely to drop (489.9 M) in 2022.
 2019 2020 2021 2022 (projected)
Interest Expense24.77 M34.88 M36.57 M39.46 M
Gross Profit325.91 M415.33 M423.71 M457.16 M

Healthequity fundamental ratios Correlations

-0.44-0.25-0.45-0.36-0.44-0.350.310.250.36-0.41-0.440.18-0.3-0.3-0.46-0.47-0.45-0.25-0.46-0.440.050.25
-0.440.770.990.780.980.660.310.25-0.860.990.980.620.790.790.960.960.950.770.941.0-0.81-0.74
-0.250.770.750.420.760.330.14-0.14-0.790.840.770.470.990.990.620.590.621.00.530.77-0.56-0.99
-0.450.990.750.731.00.610.250.21-0.870.981.00.560.780.780.970.970.970.750.961.0-0.82-0.73
-0.360.780.420.730.670.980.570.6-0.620.770.670.780.460.460.670.760.660.420.720.78-0.67-0.37
-0.440.980.761.00.670.540.20.16-0.860.971.00.520.780.780.980.960.980.760.950.99-0.8-0.74
-0.350.660.330.610.980.540.570.61-0.510.660.530.740.360.360.540.630.520.330.590.65-0.59-0.27
0.310.310.140.250.570.20.570.88-0.10.290.20.840.110.110.220.240.220.140.250.31-0.41-0.06
0.250.25-0.140.210.60.160.610.88-0.110.210.150.69-0.13-0.130.230.310.22-0.140.310.24-0.380.21
0.36-0.86-0.79-0.87-0.62-0.86-0.51-0.1-0.11-0.91-0.86-0.45-0.82-0.82-0.77-0.85-0.76-0.79-0.76-0.860.670.8
-0.410.990.840.980.770.970.660.290.21-0.910.970.630.860.860.910.920.90.840.880.99-0.79-0.82
-0.440.980.771.00.671.00.530.20.15-0.860.970.510.790.790.980.960.970.770.950.99-0.8-0.75
0.180.620.470.560.780.520.740.840.69-0.450.630.510.470.470.480.510.480.470.490.62-0.62-0.41
-0.30.790.990.780.460.780.360.11-0.13-0.820.860.790.471.00.640.630.640.990.570.8-0.55-0.99
-0.30.790.990.780.460.780.360.11-0.13-0.820.860.790.471.00.640.630.640.990.570.8-0.55-0.99
-0.460.960.620.970.670.980.540.220.23-0.770.910.980.480.640.640.981.00.620.990.96-0.81-0.59
-0.470.960.590.970.760.960.630.240.31-0.850.920.960.510.630.630.980.970.590.990.96-0.81-0.57
-0.450.950.620.970.660.980.520.220.22-0.760.90.970.480.640.641.00.970.620.990.95-0.81-0.59
-0.250.771.00.750.420.760.330.14-0.14-0.790.840.770.470.990.990.620.590.620.530.77-0.56-0.99
-0.460.940.530.960.720.950.590.250.31-0.760.880.950.490.570.570.990.990.990.530.94-0.8-0.51
-0.441.00.771.00.780.990.650.310.24-0.860.990.990.620.80.80.960.960.950.770.94-0.81-0.74
0.05-0.81-0.56-0.82-0.67-0.8-0.59-0.41-0.380.67-0.79-0.8-0.62-0.55-0.55-0.81-0.81-0.81-0.56-0.8-0.810.52
0.25-0.74-0.99-0.73-0.37-0.74-0.27-0.060.210.8-0.82-0.75-0.41-0.99-0.99-0.59-0.57-0.59-0.99-0.51-0.740.52
Click cells to compare fundamentals

Healthequity Account Relationship Matchups

Healthequity fundamental ratios Accounts

201720182019202020212022 (projected)
Receivables21.6 M25.67 M70.86 M72.77 M87.43 M94.33 M
Accounts Payable2.42 M3.52 M3.98 M1.61 M27.54 M29.72 M
Total Assets369.16 M510.02 M2.56 B2.71 B3.11 B3.35 B
Current Assets265.4 M394.68 M297.3 M460.18 M351.34 M316.71 M
Assets Non Current103.76 M115.34 M2.27 B2.25 B2.76 B2.97 B
Cash and Equivalents199.47 M361.48 M191.73 M328.8 M225.41 M214.87 M
Cash and Equivalents USD199.47 M361.48 M191.73 M328.8 M225.41 M214.87 M
Shareholders Equity346.27 M477.08 M1.03 B1.38 B1.85 B2 B
Shareholders Equity USD346.27 M477.08 M1.03 B1.38 B1.85 B2 B
Goodwill and Intangible Assets88.29 M84.32 M2.12 B2.09 B2.62 B2.83 B
Total Liabilities22.89 M32.94 M1.53 B1.33 B1.25 B1.35 B
Current Liabilities20.49 M29.05 M151.94 M204.7 M153.19 M165.28 M
Liabilities Non Current2.4 M3.88 M1.38 B1.13 B1.1 B1.19 B
Trade and Non Trade Payables2.42 M3.52 M3.98 M1.61 M27.54 M29.72 M
Property Plant and Equipment Net7.84 M8.22 M116.66 M118.61 M86.98 M93.85 M
Trade and Non Trade Receivables21.6 M25.67 M70.86 M72.77 M87.43 M94.33 M
Accumulated Retained Earnings Deficit85.3 M171.85 M211.51 M220.35 M176.06 M141.49 M
Tax Assets1.61 M5.46 M1.68 M18 K16.2 K16.63 K

Be your own money manager

Our tools can tell you how much better you can do entering a position in Healthequity without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Headlines Timeline Now

   

Headlines Timeline

Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Healthequity using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check Risk vs Return Analysis. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.96
Market Capitalization
5.1 B
Quarterly Revenue Growth YOY
0.12
Return On Assets
0.0059
Return On Equity
-0.0299
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.